Novavax begins Phase 3 testing of COVID-19 vaccine candidate

The candidate made by Novavax Inc. is the fifth to reach final-stage testing in the U.S. Some 30,000 volunteers are needed to prove if this vaccine — a different kind than its Pfizer and Moderna competitors — really works and is safe.